Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A from the PICASSO Trial

Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A from the PICASSO Trial

Background and purpose Whether pharmacologically altered high-density lipoprotein cholesterol (HDL-C) affects the risk of cardiovascular events is unknown. Recently, we have reported the Prevention of Cardiovascular Events in Asian Patients with Ischaemic Stroke at High Risk of Cerebral Haemorrhage...

Full description

Bibliographic Details
Main Authors: Eun-Jae Lee, Sun U. Kwon, Jong-Ho Park, Yong-Jae Kim, Keun-Sik Hong, Sungwook Yu, Yang-Ha Hwang, Ji Sung Lee, Juneyoung Lee, Joung-Ho Rha, Sung Hyuk Heo, Sung Hwan Ahn, Woo-Keun Seo, Jong-Moo Park, Ju-Hun Lee, Jee-Hyun Kwon, Sung-Il Sohn, Jin-Man Jung, Hahn Young Kim, Eung-Gyu Kim, Sung Hun Kim, Jae-Kwan Cha, Man-Seok Park, Hyo Suk Nam, Dong-Wha Kang
Format: Article
Language:English
Published: Korean Stroke Society 2020-01-01
Series:Journal of Stroke
Subjects:
cholesterol, hdl
secondary prevention
cilostazol
probucol
cholesterol ester transfer proteins
Online Access:http://www.j-stroke.org/upload/pdf/jos-2019-02551.pdf

Internet

http://www.j-stroke.org/upload/pdf/jos-2019-02551.pdf

Similar Items